The Genomic Medicines business is focused on developing proprietary technologies for high-growth genomics applications.
Filing excerpt
The business has developed proprietary technologies for genomics applications such as next generation sequencing, CRISPR genome editing, qPCR, and RNA interference.
What this signalsFilings often name leadership changes, deals and spending plans.
Technologies
sec-10kproductLaunchGet every 10-K signal for Danaher and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Danaher this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/9c78eea4-c4df-42d1-99ad-b30fcb492a07 returns this record as JSON. POST /v1/companies/enrich returns every signal for danaher.com.
{
"signal_id": "9c78eea4-c4df-42d1-99ad-b30fcb492a07",
"signal_type": "sec-10k",
"signal_subtype": "productLaunch",
"detected_at": "2026-03-03T05:50:06.992+00:00",
"company": {
"name": "Danaher",
"domain": "danaher.com"
},
"data": {
"detail": "The Genomic Medicines business is focused on developing proprietary technologies for high-growth genomics applications. This R&D focus requires investment in advanced lab equipment, data analysis software, and specialized materials, presenting opportunities for suppliers in the genomics and bioinformatics space.",
"summary": "Developing proprietary technologies for CRISPR, next-gen sequencing, and RNA interference applications.",
"excerpts": "The business has developed proprietary technologies for genomics applications such as next generation sequencing, CRISPR genome editing, qPCR, and RNA interference.",
"relevance": 0.8,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/313616/000031361626000062/dhr-20251231.htm",
"filing_date": "2026-02-24",
"filing_year": 2026,
"fiscal_year_end": "12/31",
"sales_relevance": "Go-to-market support",
"signal_category": "strategic",
"technologies_mentioned": [
"next generation sequencing",
"CRISPR genome editing",
"qPCR",
"RNA interference",
"genomics"
]
}
}
curl https://signals.autobound.ai/v1/signals/9c78eea4-c4df-42d1-99ad-b30fcb492a07 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"danaher.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.